 | • レポートコード：QYR9NV11071 • 出版社/出版日：QYResearch / 2019年11月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、組み換えヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組み換えヒトエンドスタチンの世界市場概要 ・組み換えヒトエンドスタチンの製造コスト構成分析 ・組み換えヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組み換えヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組み換えヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他） ・組み換えヒトエンドスタチンのセグメント分析（用途別） （医療、科学研究、その他） ・組み換えヒトエンドスタチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Thermo Fisher Scientific、ELISA、） ・組み換えヒトエンドスタチンの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Endostatin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Human Endostatin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Thermo Fisher Scientific
ELISA
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Purity:95%
Others
Segment by Application
Medical Care
Scientific Research
Others
Table of Contents
Executive Summary
1 Industry Overview of Recombinant Human Endostatin
1.1 Definition of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Segment by Type
1.2.1 Global Recombinant Human Endostatin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Purity:95%
1.2.3 Others
1.3 Recombinant Human Endostatin Segment by Applications
1.3.1 Global Recombinant Human Endostatin Consumption Comparison by Applications (2014-2025)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Human Endostatin Overall Market
1.4.1 Global Recombinant Human Endostatin Revenue (2014-2025)
1.4.2 Global Recombinant Human Endostatin Production (2014-2025)
1.4.3 North America Recombinant Human Endostatin Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Human Endostatin Status and Prospect (2014-2025)
1.4.5 China Recombinant Human Endostatin Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Human Endostatin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Human Endostatin Status and Prospect (2014-2025)
1.4.8 India Recombinant Human Endostatin Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Human Endostatin
2.3 Manufacturing Process Analysis of Recombinant Human Endostatin
2.4 Industry Chain Structure of Recombinant Human Endostatin
3 Development and Manufacturing Plants Analysis of Recombinant Human Endostatin
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Human Endostatin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Human Endostatin
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Recombinant Human Endostatin Production and Capacity Analysis
4.2 Recombinant Human Endostatin Revenue Analysis
4.3 Recombinant Human Endostatin Price Analysis
4.4 Market Concentration Degree
5 Recombinant Human Endostatin Regional Market Analysis
5.1 Recombinant Human Endostatin Production by Regions
5.1.1 Global Recombinant Human Endostatin Production by Regions
5.1.2 Global Recombinant Human Endostatin Revenue by Regions
5.2 Recombinant Human Endostatin Consumption by Regions
5.3 North America Recombinant Human Endostatin Market Analysis
5.3.1 North America Recombinant Human Endostatin Production
5.3.2 North America Recombinant Human Endostatin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Human Endostatin Import and Export
5.4 Europe Recombinant Human Endostatin Market Analysis
5.4.1 Europe Recombinant Human Endostatin Production
5.4.2 Europe Recombinant Human Endostatin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Human Endostatin Import and Export
5.5 China Recombinant Human Endostatin Market Analysis
5.5.1 China Recombinant Human Endostatin Production
5.5.2 China Recombinant Human Endostatin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Human Endostatin Import and Export
5.6 Japan Recombinant Human Endostatin Market Analysis
5.6.1 Japan Recombinant Human Endostatin Production
5.6.2 Japan Recombinant Human Endostatin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Human Endostatin Import and Export
5.7 Southeast Asia Recombinant Human Endostatin Market Analysis
5.7.1 Southeast Asia Recombinant Human Endostatin Production
5.7.2 Southeast Asia Recombinant Human Endostatin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Human Endostatin Import and Export
5.8 India Recombinant Human Endostatin Market Analysis
5.8.1 India Recombinant Human Endostatin Production
5.8.2 India Recombinant Human Endostatin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Human Endostatin Import and Export
6 Recombinant Human Endostatin Segment Market Analysis (by Type)
6.1 Global Recombinant Human Endostatin Production by Type
6.2 Global Recombinant Human Endostatin Revenue by Type
6.3 Recombinant Human Endostatin Price by Type
7 Recombinant Human Endostatin Segment Market Analysis (by Application)
7.1 Global Recombinant Human Endostatin Consumption by Application
7.2 Global Recombinant Human Endostatin Consumption Market Share by Application (2014-2019)
8 Recombinant Human Endostatin Major Manufacturers Analysis
8.1 Thermo Fisher Scientific
8.1.1 Thermo Fisher Scientific Recombinant Human Endostatin Production Sites and Area Served
8.1.2 Thermo Fisher Scientific Product Introduction, Application and Specification
8.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 ELISA
8.2.1 ELISA Recombinant Human Endostatin Production Sites and Area Served
8.2.2 ELISA Product Introduction, Application and Specification
8.2.3 ELISA Recombinant Human Endostatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
9 Development Trend of Analysis of Recombinant Human Endostatin Market
9.1 Global Recombinant Human Endostatin Market Trend Analysis
9.1.1 Global Recombinant Human Endostatin Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Human Endostatin Regional Market Trend
9.2.1 North America Recombinant Human Endostatin Forecast 2019-2025
9.2.2 Europe Recombinant Human Endostatin Forecast 2019-2025
9.2.3 China Recombinant Human Endostatin Forecast 2019-2025
9.2.4 Japan Recombinant Human Endostatin Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Human Endostatin Forecast 2019-2025
9.2.6 India Recombinant Human Endostatin Forecast 2019-2025
9.3 Recombinant Human Endostatin Market Trend (Product Type)
9.4 Recombinant Human Endostatin Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Human Endostatin Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Recombinant Human Endostatin
Table Global Recombinant Human Endostatin Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Human Endostatin Production Market Share by Types in 2018
Figure Purity:95% Product Picture
Figure Others Product Picture
Table Global Recombinant Human Endostatin Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Recombinant Human Endostatin Consumption Market Share by Applications in 2018
Figure Medical Care
Figure Scientific Research
Figure Others
Figure Global Recombinant Human Endostatin Revenue (Million USD) (2014-2025)
Figure Global Recombinant Human Endostatin Production (K Pcs) (2014-2025)
Figure North America Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Figure China Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Figure India Recombinant Human Endostatin Market Size (Million USD) (2014-2025)
Table Recombinant Human Endostatin Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Human Endostatin in 2018
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Industry Chain Structure of Recombinant Human Endostatin
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Human Endostatin Manufacturing Plants Distribution
Table Recombinant Human Endostatin Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Human Endostatin Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Recombinant Human Endostatin Production (K Pcs) of Major Manufacturers (2014-2019)
Table Recombinant Human Endostatin Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Human Endostatin Production Share by Manufacturers in 2018
Table Recombinant Human Endostatin Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Human Endostatin Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Human Endostatin Revenue Share by Manufacturers in 2018
Table Recombinant Human Endostatin Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Human Endostatin Production by Regions 2014-2019 (K Pcs)
Table Global Recombinant Human Endostatin Production Market Share by Regions 2014-2019
Figure Global Recombinant Human Endostatin Production Market Share by Regions in 2018
Table Global Recombinant Human Endostatin Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Human Endostatin Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Human Endostatin Revenue Market Share by Regions in 2018
Table Global Recombinant Human Endostatin Consumption by Regions 2014-2019 (K Pcs)
Table Global Recombinant Human Endostatin Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure North America Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure Europe Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure China Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure China Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure Japan Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure India Recombinant Human Endostatin Production Growth Rate 2014-2019 (K Pcs)
Figure India Recombinant Human Endostatin Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Human Endostatin Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Recombinant Human Endostatin Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Human Endostatin Market Share by Application (2014-2019)
Table Thermo Fisher Scientific Recombinant Human Endostatin Production Sites and Area Served
Table Thermo Fisher Scientific Recombinant Human Endostatin Product Introduction, Application and Specification
Table Thermo Fisher Scientific Recombinant Human Endostatin Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Recombinant Human Endostatin Production Growth Rate (2014-2019)
Table Thermo Fisher Scientific Recombinant Human Endostatin Production Market Share (2014-2019)
Figure Thermo Fisher Scientific Recombinant Human Endostatin Revenue Market Share (2014-2019)
Table Thermo Fisher Scientific Recombinant Human Endostatin Main Business and Markets Served
Table ELISA Recombinant Human Endostatin Production Sites and Area Served
Table ELISA Recombinant Human Endostatin Product Introduction, Application and Specification
Table ELISA Recombinant Human Endostatin Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ELISA Recombinant Human Endostatin Production Growth Rate (2014-2019)
Table ELISA Recombinant Human Endostatin Production Market Share (2014-2019)
Figure ELISA Recombinant Human Endostatin Revenue Market Share (2014-2019)
Table ELISA Recombinant Human Endostatin Main Business and Markets Served
Figure Global Recombinant Human Endostatin Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Recombinant Human Endostatin Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Human Endostatin Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Human Endostatin Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Recombinant Human Endostatin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Recombinant Human Endostatin by Type (2019-2025)
Table Global Consumption (K Pcs) of Recombinant Human Endostatin by Application (2019-2025)
Table Recombinant Human Endostatin Distributors List
Table Recombinant Human Endostatin Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
組み換えヒトエンドスタチンのグローバル市場調査 2019年 The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global…- ヒトエンドスタチンのグローバル市場調査 2019年 The global Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this repor…
- 世界の組換えヒトインスリン産業調査2019-2025 Insulin is a well-characterized peptide that can be produced byrecombinant DNA technology for human therapeutic use.In 2018, the global Recombinant Human Insulin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been …
- 世界の組換えヒトインスリン産業調査2019-2025 Insulin is a well-characterized peptide that can be produced byrecombinant DNA technology for human therapeutic use.In 2018, the global Recombinant Human Insulin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been …
- 組換えヒト血清アルブミンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human serum albumin is the serum albuminfound in human blood. It is the most abundant protein in human blood plasma; it constitutes about half of serum protein. It is produced in the liver. It is soluble and monomeric. Scope of the Report: This report focuses on the Recombinant Human Serum Albumin i…